Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytokine inhibition with anakinra in chronic fatigue syndrome – pilot study
2013-005466-19Phase 3Completed
- Sponsor
- Radboudumc
- Start
- Feb 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myalgic encephalomyelitis (ME) comparing Anakinra with Placebo (2 arms). Primary endpoint: Fatigue severity (CIS). Started Feb 2014; status: completed.
02
Drugs
anakinra
03
Conditions
myalgic encephalomyelitis (ME)
Beyond the preview
Go deeper on 2013-005466-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005466-19.